Recap: EyePoint Pharmaceuticals Q1 Earnings

Recap: EyePoint Pharmaceuticals Q1 Earnings


EyePoint Pharmaceuticals EYPT reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.


EyePoint Pharmaceuticals beat estimated earnings by 3.45%, reporting an EPS of $-0.56 versus an estimate of $-0.58.

Revenue was up $1.97 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.06 which was followed by a 1.15% increase in the share price the next day.

Here's a look at EyePoint Pharmaceuticals's past performance:


Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.53 -0.40 -0.43 -0.46
EPS Actual -0.59 -0.58 -0.42 -0.50
Revenue Estimate 9.80M 9.84M 9.13M 7.93M
Revenue Actual 11.54M 9.06M 9.01M 7.32M

To track all earnings releases for EyePoint Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarningsNews